HK1223011A1 - 大葉冬青提取物為有效成分的藥物組合物 - Google Patents

大葉冬青提取物為有效成分的藥物組合物

Info

Publication number
HK1223011A1
HK1223011A1 HK16109136.8A HK16109136A HK1223011A1 HK 1223011 A1 HK1223011 A1 HK 1223011A1 HK 16109136 A HK16109136 A HK 16109136A HK 1223011 A1 HK1223011 A1 HK 1223011A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
active ingredient
composition containing
containing extract
ilex latifolia
Prior art date
Application number
HK16109136.8A
Other languages
English (en)
Inventor
成蓮姬
裴起煥
劉載國
金鎮杓
Original Assignee
Hankook Pharm Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hankook Pharm Co Inc filed Critical Hankook Pharm Co Inc
Publication of HK1223011A1 publication Critical patent/HK1223011A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK16109136.8A 2010-08-13 2016-08-01 大葉冬青提取物為有效成分的藥物組合物 HK1223011A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100078374A KR20120015874A (ko) 2010-08-13 2010-08-13 일렉스 라티폴리아 추출물을 유효성분으로 함유하는 허혈성 질환 또는 퇴행성 뇌질환의 예방 또는 치료용 또는, 기억손상 개선용 약학적 조성물

Publications (1)

Publication Number Publication Date
HK1223011A1 true HK1223011A1 (zh) 2017-07-21

Family

ID=45790260

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16109136.8A HK1223011A1 (zh) 2010-08-13 2016-08-01 大葉冬青提取物為有效成分的藥物組合物

Country Status (5)

Country Link
JP (1) JP5358627B2 (zh)
KR (1) KR20120015874A (zh)
CN (2) CN105311071A (zh)
HK (1) HK1223011A1 (zh)
TW (1) TWI437998B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150041223A (ko) * 2013-10-04 2015-04-16 보령제약 주식회사 피마살탄을 포함하는 허혈성 뇌질환 예방 또는 치료용 약학적 조성물
KR102099087B1 (ko) 2018-09-04 2020-05-15 곽민재 탈모방지 또는 발모개선용 조성물
CN109528739B (zh) * 2019-01-10 2020-08-25 河南中医药大学 冬青苷o在制备防治老年痴呆的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003113026A (ja) * 2001-10-05 2003-04-18 Ichimaru Pharcos Co Ltd リパーゼ活性促進剤
JP4544503B2 (ja) * 2003-04-15 2010-09-15 株式会社アミノアップ化学 雲南苦丁茶成分を含有する組成物
CN101099754A (zh) * 2006-07-07 2008-01-09 李超生 具栖冬青苷的制备方法及应用
CN101284031B (zh) * 2008-06-03 2011-05-04 上海雷允上科技发展有限公司 毛冬青提取物、其制备及应用
CN101366738B (zh) * 2008-10-09 2011-05-11 河南中医学院 毛冬青总黄酮在制备防治短暂脑缺血综合症药物的应用
KR101054943B1 (ko) * 2008-11-14 2011-08-05 조선대학교산학협력단 쿠딩차 추출물로부터 항산화 활성을 갖는 페놀릭 화합물 및이를 유효성분으로 포함하는 기능성식품

Also Published As

Publication number Publication date
JP2012041340A (ja) 2012-03-01
KR20120015874A (ko) 2012-02-22
JP5358627B2 (ja) 2013-12-04
TWI437998B (zh) 2014-05-21
CN102370675B (zh) 2017-06-09
CN105311071A (zh) 2016-02-10
CN102370675A (zh) 2012-03-14
TW201206454A (en) 2012-02-16

Similar Documents

Publication Publication Date Title
IL233200A0 (en) The history of alpha-boronic acid, its preparation and pharmaceutical preparations containing it
EP2535339A4 (en) POLYMORPHES OF DASATINIB, METHOD OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
IL225626A0 (en) The history of pyrrolidinone, their preparation and remote preparations containing them
SG11201406141UA (en) Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient
IL225824A0 (en) History of quinoxaline, their preparation and pharmaceutical preparations containing them
IL226094A0 (en) The history of pyrazine, their preparation and pharmaceutical preparations containing them
EP2468771A4 (en) PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE
ZA201400336B (en) Fatty acid composition and plant extract and pharmaceutical preparation and application thereof
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
EP2743275A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING A HONEY CHERRY EXTRACT AND ANTIBIOTICS, PHARMACEUTICAL KIT, AND USE OF A HONEY CHERRY EXTRACT FOR THE MANUFACTURE OF MEDICAMENTS
HK1179962A1 (zh) 三環吲唑化合物、製備方法和含有它的藥物組合物
HK1188791A1 (zh) 新型八氫噻吩並喹啉衍生物、包含所述衍生物的藥物組合物及它們的用途
IL230219B (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
ZA201302012B (en) Low dose pharmaceutical composition
HK1223011A1 (zh) 大葉冬青提取物為有效成分的藥物組合物
EP2548565A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES CONTAINING QUAMOCLIT ANGULATA EXTRACTS
EP2871187A4 (en) NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
IL206739A (en) An injectable drug containing silitol as an active substance
EP2815759A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING THE EXTRACT OF LIRIODENDRON TULIPIFERA AS AN ACTIVE SUBSTANCE
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
EP2815742A4 (en) IMPROVED ADMINISTRATIVE FORM WITH EXTRACT FROM THE RINDER OF LIRIODENDRON TULIPIFERA AS AN ACTIVE SUBSTANCE
HU1000299D0 (en) Nanostructured atorvastatin, its pharmaceutically acceptable salts and pharmaceutical compositions containing them and process for their preparation
EP2896625A4 (en) CO-CRYSTAL OF PIPÉRACILLIN SODIUM AND SULBACTAM SODIUM AND PROCESS FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF
SI2474529T1 (sl) Kristalne oblike aktivne farmacevtske učinkovine